| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-05 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-05 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.16 | 8e-05 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.18 | 0.0002 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.24 | 0.0002 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |